LADY LOVE KALTENHAUSER: Open Payments
NPI 1831770593 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 37 payments from 20 companies in 2025. Trend: 2023 $803 · 2024 $958 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $120 |
| Novo Nordisk Inc | 3 | $89 |
| Calliditas Therapeutics US Inc. | 3 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $55 |
| Travere Therapeutics, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $50 |
| Amgen Inc. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $38 |
Products named: TARPEYO, JARDIANCE, LOKELMA, Kerendia, Rivfloza, BENLYSTA, Veltassa, KRYSTEXXA.
Industry payments across CO — which companies pay providers there.
